AtonRa Partners - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 227 filers reported holding FATE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
AtonRa Partners ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$74,300
-50.6%
13,035
-12.6%
0.11%
-43.8%
Q4 2022$150,462
-64.6%
14,912
-21.3%
0.19%
-54.1%
Q3 2022$425,000
-12.0%
18,946
-2.7%
0.42%
-5.9%
Q2 2022$483,000
-39.8%
19,474
-5.9%
0.44%
+1.8%
Q1 2022$802,000
-15.0%
20,697
+28.3%
0.44%
+32.9%
Q4 2021$944,000
+9.9%
16,138
+11.3%
0.33%
+14.3%
Q3 2021$859,000
-57.3%
14,494
-37.6%
0.29%
-61.2%
Q2 2021$2,014,000
+11.7%
23,211
+6.1%
0.74%
-8.1%
Q1 2021$1,803,000
-15.3%
21,867
-6.6%
0.80%
-23.0%
Q4 2020$2,128,00023,4071.04%
Other shareholders
FATE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$197,709,00022.51%
Redmile Group, LLC 12,957,222$758,127,00017.24%
Grosvenor Holdings, L.L.C. 1,037,256$60,690,0006.28%
Casdin Capital, LLC 3,400,000$198,934,0005.61%
Ally Bridge Group (NY) LLC 270,000$15,798,0005.52%
DAFNA Capital Management LLC 372,160$21,775,0005.48%
Tri Locum Partners LP 142,032$8,310,0003.27%
Kynam Capital Management, LP 95,561$5,591,0002.99%
Artal Group S.A. 1,800,000$105,318,0002.86%
Bellevue Group AG 3,775,736$220,918,0002.28%
View complete list of FATE THERAPEUTICS INC shareholders